Simona Duranti

Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

Giulio Metro, Rita Chiari, Simona Duranti et al. · Lung Cancer · 2012 · 69 citations

Clinical Outcome, Specific Mutant Kras, Medicine +10

Long-Term Response to Gefitinib and Crizotinib in Lung Adenocarcinoma Harboring Both Epidermal Growth Factor Receptor Mutation and <i>EML4-ALK</i> Fusion Gene

Rita Chiari, Simona Duranti, Vienna Ludovini et al. · Journal of Clinical Oncology · 2014 · 42 citations · Full text

Tumor Biology, Medicine, Cancer Growth +11

Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years

Rosa Falcone, Pasquale Lombardi, Marco Filetti et al. · Cancers · 2022 · 30 citations · Full text

Solid Tumors, Cancer Management, Oncologic Drugs Approval +23

Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center

Camilla Nero, Simona Duranti, Flavia Giacomini et al. · Journal of Personalized Medicine · 2022 · 21 citations · Full text

Cancer Molecular Characterization, Genetic Epidemiology, Pathology +20

Pharmacokinetics of Oxaliplatin in a Hemodialyzed Patient: Chemotherapy Dose Adjustment and Timing of Dialysis

Stefania Gori, Gianluigi Lunardi, Alessandro Inno et al. · Clinical Colorectal Cancer · 2014 · 19 citations

Oncology, Medicine, Chemotherapy Dose Adjustment +7